📰 Immune Modulation News
Page 2 - Immune Modulation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immune Modulation. Real-time updates on events, politics, business and more.
December 9, 2021
/PRNewswire/ -- OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera...
December 9, 2021
/PRNewswire/ -- OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera...
October 20, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
July 20, 2021
with strong interpersonal communication skills to join the talented Cancer Immunology & Immune Modulation (CI & IM) Research Group at Boehringer Ingelheim’s US research facility in Ridgefield, CT. The successful candidate will work within the CI&IM in vivo pharmacology group to advance both exploratory and drug candidate discovery programs and provide target discovery/validation, in-vivo efficacy, mechanism of action (MOA) and pharmacodynamic data essential to drive projects into clinic...